DTaP-IPV/Hib

BIOLOGICAL3 trials

Sponsors

Sanofi Pasteur, a Sanofi Company, Novartis Vaccines

Conditions

DiphtheriaHaemophilus InfectionsHaemophilus InfluenzaeMeningococcal DiseasePertussisPolioTetanus

Phase 3

A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months

CompletedNCT01000311

Novartis VaccinesMeningococcal Disease

Start: 2009-11-30End: 2011-11-30Updated: 2014-04-21

Unknown Phase

Database Surveillance Safety Study of PENTACEL® Vaccine

CompletedNCT00804284

Sanofi Pasteur, a Sanofi CompanyDiphtheria, Tetanus, Pertussis +1

Start: 2008-09-30End: 2015-01-31Updated: 2015-08-19

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

CompletedNCT00855855

Sanofi Pasteur, a Sanofi CompanyHaemophilus Infections, Diphtheria, Tetanus +2

Start: 2009-02-28End: 2014-12-31Updated: 2022-04-25

Related Papers

Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers

Vaccine2016-07-0129 citations